AUA 2022: Update From the PEDAL Trial: A Prospective Single Arm Paired Comparison of Ability To Diagnose and Locate Prostate Cancer Between Multiparametric MRI and 18F-PSMA-PET/CT
AUA 2022 the PEDAL trial comparing multiparametric MRI and 18F-DCFPyl prostate specific membrane antigen (PSMA)-PET/CT in the diagnosis and localization of prostate cancer.